Monthly Archives: November 2019
REDCap training, “Getting Started with Forms and Surveys” to be Dec. 3
NCI “Moonshot” grant to boost hereditary cancer identification
Collecting family health histories to identify patients at risk for hereditary cancers may seem a simple task, but it’s a complicated endeavor due to the multitude of ways information is compiled. Continue reading
Clinic a haven for children with vascular malformations
When Kim Shrader and her husband, Wayne, adopted their son, Riley, six years ago, they knew he had a rare, genetic disorder that would require medical interventions. Continue reading
VUMC Limited Submission Opportunity: CDC Modeling Infectious Diseases in Healthcare Research Projects; deadline is Dec. 16
Karijolich, Shoemaker, Kropski to deliver today’s Cutting-Edge Discovery Lecture
Antiviral immunity, obesity and pulmonary fibrosis will be discussed by three Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Nov. 21. The lecture will begin at 4 p.m. in 208 Light Hall. Continue reading
New Physician Spotlight: CJ Plummer, Physical Medicine and Rehabilitation
Clausyl “CJ” Plummer, MD, has joined Vanderbilt University Medical Center after completing a fellowship in brain injury medicine at the University of Washington. He began seeing patients Oct. 14. Continue reading
Madalyn Durbin’s dad just had a double lung transplant; surely there was no way he could make it to her wedding.
Never underestimate a father’s determination to be there for his daughter. As Madalyn started down the aisle, Terry stepped out and took her hand. Continue reading
Cell and Developmental Biology lecture by Chris Halbrook is Dec. 2
Roden wins Schottenstein Prize from Ohio State University
Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, has been awarded the 2019 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences by The Ohio State University Wexner Medical Center’s Heart a… Continue reading
Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Diseases Caused by TTC7A Deficiency
Mutations in the tetratricopeptide repeat domain 7A gene (TTC7A) cause intestinal epithelial and immune defects. Patients can become immune deficient and develop apoptotic enterocolitis, multiple intestinal atresia, and recurrent intestinal stenosis. T… Continue reading